NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Elemental Enzymes

Elemental Enzymes

Private
Saint Louis, MichiganHealthcare & Life Scienceshttps://elementalenzymes.com/

Last Round

Growth Equity

Jun 5, 2023

Total Funding Raised

$77.75M

Company Overview

Elemental Enzymes is an agricultural biotechnology company that develops and manufactures enzyme, peptide, and biochemical solutions to enhance soil and plant health, nutrient uptake, and crop yields.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologyagricultural inputscrop protectionbiologicalsagtechcitrus greeningbiochemical solutionspeptide-based solutionsplant healthbio-pesticidesagribusinesscrop yieldbiotech R&Dsustainable agriculture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elemental Enzymes Comparables

Compare Elemental Enzymes with similar companies based on industry and business-model similarity.

Elemental Enzymes comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Invaio Sciences
81%
Micropep
80%
GreenLight Biosciences Holdings, PBC
79%

Elemental Enzymes Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityJun 5, 2023

Key People

Founding team and executive leadership

Katie Thompson

Cofounder, C.O.O., Co-founder, Chief Operating Officer

Founding Team

Brian Thompson

Chief Executive Officer

Executive Team

Mark Deadwyler

Chief Financial Officer

Executive Team

Elemental Enzymes Investors

Notable investors and investment history

Elemental Enzymes investors
InvestorRounds
Centennial InvestorsSeed, Growth Equity
Missouri Technology CorporationSeed, Growth Equity
St. Louis Arch AngelsSeed, Growth Equity
Allen Angel Capital Education ProgramSeed
Paine Schwartz PartnersGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 5, 2023

    $78M round led by Paine Schwartz Partners.

Elemental Enzymes Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elemental Enzymes Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elemental Enzymes's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint Louis, Michigan
Employee Range92
Year Founded2011
Last FundingJun 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.